Clinical efficacy and influcing factors of autologous transplantation of bone marrow mononuclear cells in the treatment of lower extremity ischemic disorders

HOU Xiang-qian,WU Xue-jun,ZHANG Jing-yong,JIN Xing,Lü Xiao-xia,ZHONG Zhen-yue,ZHANG Shi-yi,DONG Dian-ning,SUN Yan
DOI: https://doi.org/10.3969/j.issn.1009-9905.2007.04.013
2007-01-01
Abstract:Objective:To observe the clinical efficacy and analyze the influcing factors of autologous transplantation of bone marrow mononuclear cells in the treatment of lower extremity ischemic disorders. Methods:Totally 28 cases were treated by autologous transplantation of bone marrow mononuclear cells. After aspiration of bone marrow blood from the iliums,the mononuclear cells were separated and then injected into the skeletal muscles of the ischemic legs. The clinical and laboratory findings were monitored after the surgery. Then the cases were divided into two groups by the concentration of the bone marrow mononuclear cells injected into the muscles. The improvement degrees of the two groups were compared. Results: The low limb pain alleviating rate was 100% as well as the skin turning warm and the insensible feeling alleviating rate, there was the sign of ulcer healing in 5 case. The clinical score after the transplantation (10.96±2.09) was lower than that before the transplantation(14.25±2.41),P<0.05. The difference value of the group treated with higher mononuclear cells before and after the plantation is significantly higher than that of the group with lower mononuclear cells. No complications was found except 1 case appeared superficial varicosis. Conclusions: Autologous transplantation of bone marrow mononuclear cells could be a safe and effective method for treating patients with lower extremity ischemic disorder. The quantity of the mononuclear cells, the extent of ischemia, especially the concentration of the mononuclear cells injected into the muscles significantly influent the result of the treatment.
What problem does this paper attempt to address?